ESC 365 - Future direction for research in risk stratification of stable CAD in patients with comorbidities.

ESC Premium Access

Future direction for research in risk stratification of stable CAD in patients with comorbidities.

Session: Risk stratification of stable coronary artery disease in patients with comorbidities

Topic: CAD and comorbidities

Speaker: Doctor M. Di Carli (Boston, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Marcelo Fernando Di Carli

Brigham and Women's Hospital, Boston (United States of America)

8 presentations

1 follower

3 more presentations in this session

State of the art in risk stratification of stable CAD in patients with comorbidities.

Speaker: Professor C. Vrints (Antwerp, BE)

Serial high sensitivity troponin I and long-term outcomes in patients with type 2 diabetes mellitus in the EXAMINE trial

Speaker: Associate Professor P. Jarolim (Boston, US)

Comparison of three chronic kidney disease epidemiology collaboration (CKD-EPI) equations for prediction of coronary plaque vulnerability: an optical coherence tomography study

Speaker: Doctor D. Jiannan (Harbin, CN)

Access the full session

Risk stratification of stable coronary artery disease in patients with comorbidities

Speakers: Doctor M. Di Carli, Professor C. Vrints, Associate Professor P. Jarolim, Doctor D. Jiannan

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources